BAIVF
Price
$0.22
Change
-$0.00 (-0.00%)
Updated
Feb 14 closing price
Capitalization
16.12M
RLYB
Price
$0.33
Change
-$0.00 (-0.00%)
Updated
May 22, 04:36 PM (EDT)
Capitalization
14.39M
76 days until earnings call
Interact to see
Advertisement

BAIVF vs RLYB

Header iconBAIVF vs RLYB Comparison
Open Charts BAIVF vs RLYBBanner chart's image
BENEVOLENTAI
Price$0.22
Change-$0.00 (-0.00%)
Volume$500
Capitalization16.12M
Rallybio
Price$0.33
Change-$0.00 (-0.00%)
Volume$300
Capitalization14.39M
BAIVF vs RLYB Comparison Chart
Loading...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAIVF vs. RLYB commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAIVF is a Hold and RLYB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (BAIVF: $0.22 vs. RLYB: $0.33)
Brand notoriety: BAIVF and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BAIVF: 100% vs. RLYB: 27%
Market capitalization -- BAIVF: $16.12M vs. RLYB: $14.39M
BAIVF [@Biotechnology] is valued at $16.12M. RLYB’s [@Biotechnology] market capitalization is $14.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAIVF’s FA Score shows that 1 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • BAIVF’s FA Score: 1 green, 4 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, RLYB is a better buy in the long-term than BAIVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLYB’s TA Score shows that 6 TA indicator(s) are bullish.

  • RLYB’s TA Score: 6 bullish, 2 bearish.

Price Growth

BAIVF (@Biotechnology) experienced а 0.00% price change this week, while RLYB (@Biotechnology) price change was +5.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

RLYB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAIVF($16.1M) has a higher market cap than RLYB($14.4M). BAIVF YTD gains are higher at: -47.619 vs. RLYB (-66.063).
BAIVFRLYBBAIVF / RLYB
Capitalization16.1M14.4M112%
EBITDAN/A-50.26M-
Gain YTD-47.619-66.06372%
P/E RatioN/AN/A-
RevenueN/A848K-
Total CashN/A54.5M-
Total DebtN/A116K-
TECHNICAL ANALYSIS
Technical Analysis
RLYB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICU1.300.01
+1.17%
SeaStar Medical Holding Corp
CAPL22.57-0.23
-1.01%
CrossAmerica Partners LP
CBAN15.39-0.34
-2.16%
Colony Bankcorp Inc
WLK73.66-2.54
-3.33%
Westlake Corp
SBRA17.28-0.79
-4.37%
Sabra Health Care REIT

BAIVF and

Correlation & Price change

A.I.dvisor tells us that BAIVF and BMEA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BAIVF and BMEA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAIVF
1D Price
Change %
BAIVF100%
N/A
BMEA - BAIVF
32%
Poorly correlated
-7.64%
RNXT - BAIVF
20%
Poorly correlated
N/A
CLYM - BAIVF
20%
Poorly correlated
-2.42%
RLYB - BAIVF
20%
Poorly correlated
-5.78%
PLRX - BAIVF
20%
Poorly correlated
-2.92%
More

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PXXLF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
-5.78%
PXXLF - RLYB
44%
Loosely correlated
N/A
PRME - RLYB
41%
Loosely correlated
-0.85%
ATXS - RLYB
41%
Loosely correlated
-8.62%
SLNO - RLYB
38%
Loosely correlated
-2.33%
GBIO - RLYB
37%
Loosely correlated
-2.16%
More